Erlanger Baroness Hospital — Chattanooga, Tennessee

Erlanger Baroness Hospital is a clinical research site located in Chattanooga, Tennessee, United States 37403.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Erlanger Baroness Hospital has participated in 5 clinical trials.

Therapeutic areas: Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Pain, Postoperative, Crohns Disease.

Sponsors: NovoCure GmbH, Jessica G Putman, Celularity Incorporated.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Erlanger Baroness Hospital?

Erlanger Baroness Hospital has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Erlanger Baroness Hospital conducted?

Erlanger Baroness Hospital has 5 clinical trials on record. Their work covers Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Pain, Postoperative, Crohns Disease.

Is Erlanger Baroness Hospital accredited by Crixeo Health?

Yes — Erlanger Baroness Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Erlanger Baroness Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.